Drug Trial Radar · NCT07843056
A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
May 10, 2022
Primary completion
Jan 20, 2026
Study completion Mar 23, 2026
Sponsor
- Lead sponsor
- EMSIndustry
- Sponsor type
- Industry
- Collaborators
- Worldwide Clinical Trials
- First posted
- Sep 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase II, proof-of-concept, national, multicenter, randomized, double-blind clinical trial to compare the efficacy and safety of WAS123 in the maintenance treatment of patients with schizophrenia, with a parallel design between 2 groups and controlled by an active comparator (Aripiprazole). A total of 121 participants were randomized and assigned to either 1 of 2 treatment groups in a 1:1 ratio.
Conditions
- Schizophenia Disorder
Interventions
WAS123Drug
oral dose
Aripiprazole (Fixed dose)Drug
oral daily dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Score PANSSTime frame: From enrollment to the end of treatment at 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinica Viver
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.